Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study Between Apremilast and Adalimumab in Psoriatic Arthritis Patients

NCT07398651 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07398651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07398651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study Between Apremilast and Adalimumab in Psoriatic Arthritis Patients
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 30, 2026
Completion date
December 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis, tnf, ultrasound assessment